Meet the Expert
Chief Operating Officer, Acumen Pharmaceuticals
- More than 30 years of domestic and international experience in the discovery, development, registration, and commercialization of chemical and biotechnology products.
- Executive leadership roles with Acumen Pharmaceuticals, Mendel Biotechnology and Monsanto, managing corporate and commercial development, negotiating contracts, drafting and executing business plans, developing intellectual property protection strategies, building and leading high performance teams.
- International experience in market analyses, product development, regulatory and public acceptance, and commercialization.
- Author of two published pharmacological research articles related to Alzheimer's Disease and the holder of eight patents or patent applications.
Session Packages from $450
Your Expert Package Includes:
- All 7 Best Practices
- Pre-Call Discovery Process
- One-on-One Call with Expert
- Session Summary Report
- Post-Session Engagement
- Forbes: Protect Your Intellectual Property – Before It's Too Late
- Western Australia: Strategies to Protect Your Intellectual Property
- Biodesign – The Process of Innovating Medical Technologies: IP Strategy
- Journal of Advanced Pharmaceutical Technology & Research: Intellectual property rights – An overview and implications in pharmaceutical industry
- Perception Partners: Innovation and IP Strategy for a Brighter Future, Faster
- Journal of Pharmacy and Bioallied Sciences: Patent protection strategies
Linking Intellectual Property Protection to Core Business Objectives: Resources